Cite
HARVARD Citation
Linke, A. et al. (2017). Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheterization and cardiovascular interventions. 90 (6), pp. 1016-1026. [Online].